共 13 条
[1]
Elevatede Creactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Fichtlscherer S,Rosenberger G,Walter DH,et al. Circulation . 2000
[2]
C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Zwaka TP,Hombach V,Torzewski J. Circulation . 2001
[3]
Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Nakagomi A,Freedman SB,Geczy CL. Circulation . 2000
[4]
T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Nakajima T,Schulte S,Warrington KJ,et al. Circulation . 2002
[5]
Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling. Penn MS,Topol EJ. Circulation Research . 2001
[6]
Unstable angina and elevated C-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. Tomai F,Crea F,Gaspardone A,et al. Circulation . 2001
[7]
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. Paul M,Ridker MD,Charles H. Henekens,et al. The New England Journal of Medicine . 2000
[8]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[9]
Generation of C-Reactive protein and complement components in atherosclerotic plaques. Yasojima K,Schwab C,McGeer EG,et al. American Journal of Pathology . 2001
[10]
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. Ridker PM,Rifai N,Clearfield M,et al. The New England Journal of Medicine . 2001